COMPARISON OF PHASE-I TRIALS OF ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR (EGFR) MONOCLONAL-ANTIBODIES (MABS) 528 AND 225 LABELED WITH I-131 ANDIN-111

Authors
SCOTT AM BASELGA J DIVGI CR PFISTER D KRIS M ZHANG JJ DAGHIGHIAN F CARMICHAEL N OETTGEN HF LARSON SM MENDELSOHN J
Citation
Am. Scott et al., COMPARISON OF PHASE-I TRIALS OF ANTIEPIDERMAL GROWTH-FACTOR RECEPTOR (EGFR) MONOCLONAL-ANTIBODIES (MABS) 528 AND 225 LABELED WITH I-131 ANDIN-111, The Journal of nuclear medicine, 34(5), 1993, pp. 213-213
Citations number
NO
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging
Journal title
The Journal of nuclear medicine → ACNP
ISSN journal
01615505
Volume
34
Issue
5
Year of publication
1993
Supplement
S
Pages
213 - 213
Database
ISI
SICI code
0161-5505(1993)34:5<213:COPTOA>2.0.ZU;2-2